Trademark: BIOTECH
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for BIOTECH
We do not have any records of a proof of use for BIOTECH at this moment.
Possible trademark infringements of BIOTECH
Basic Information about BIOTECH
- Serial Number
- 87681772
- Filing Date
- 13 Nov 2017
- Registration Number
- 5796866
- Registration Date
- 09 Jul 2019
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of BIOTECH on the blockchain with WikiTrademarks.io.
- First use of BIOTECH anywhere
- BIOTECH was first used on 30 Nov 2000 for the primary classification of goods and services, international, 009 (Electrical and scientific apparatus)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 009
- US Codes
- 021; 023; 026; 036; 038
- First use of BIOTECH anywhere
- BIOTECH was first used on 30 Nov 2000 for the primary classification of goods and services, international, 025 (Clothing)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 025
- US Codes
- 022; 039
Who owns BIOTECH?
Correspondent
- MICHELLE LEVIN LEASON ELLIS LLP
- ONE BARKER AVENUE, FIFTH FLOOR
- WHITE PLAINS, NY 10601
- UNITED STATES
Recent News about BIOTECH
Reactions to Amgen: Hard Work Ahead for Biotech Innovators and Attorneys Trying to Enable Genus Claims Tweet this
ArentFox Schiff is Seeking a Biotech Patent Agent/Technical Specialist Tweet this
SCOTUS Takes on Scope of Enablement Inquiry in Amgen v. Sanofi: Implications for Pharma/ Biotech and Beyond Tweet this
Review Not Warranted: SG Tells SCOTUS to Scrap Amgen’s Case on Enablement Test for Biotech Patents Tweet this
Other Barks & Bites for Friday, September 16: IPWatchdog LIVE Takes Over Renaissance Richardson Dallas, Biden Issues Executive Order on Biotech Innovation, and EGC Affirms Ruling Against Google’s Android Restrictions Tweet this
In an increasingly hot biotech market, protecting IP is key Tweet this
CAFC Denies Amgen Petition to Reconsider Enablement Test for Biotech Patents Tweet this
TRIPS IP Waiver Could Establish Dangerous Precedent for Climate Change and Other Biotech Sectors Tweet this
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io